Fusion Family Wealth’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-52
Closed -$9K 124
2020
Q1
$9K Buy
52
+37
+247% +$6.97K ﹤0.01% 90
2019
Q4
$3K Sell
15
-161
-91% -$29K ﹤0.01% 121
2019
Q3
$30K Buy
176
+79
+81% +$12.9K 0.01% 78
2019
Q2
$16K Buy
97
+82
+547% +$11.4K ﹤0.01% 105
2019
Q1
$2K Sell
15
-82
-85% -$11.9K ﹤0.01% 139
2018
Q4
$13K Hold
97
﹤0.01% 177
2018
Q3
$18K Sell
97
-2,903
-97% -$533K ﹤0.01% 174
2018
Q2
$6K Buy
3,000
+2,903
+2,993% +$466K ﹤0.01% 233
2018
Q1
$16K Hold
97
0.01% 184
2017
Q4
$16K Buy
97
+82
+547% +$14.7K ﹤0.01% 195
2017
Q3
$3K Sell
15
-82
-85% -$19.1K ﹤0.01% 194
2017
Q2
$24K Hold
97
0.01% 159
2017
Q1
$23K Sell
97
-172
-64% -$40.1K 0.01% 158
2016
Q4
$58K Buy
+269
New +$55.7K 0.03% 115

Other funds holding AGN

Fusion Family Wealth's AGN Position: Q2 2020 in Review

Fusion Family Wealth sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 52 shares — an estimated $9K sold.

Fusion Family Wealth first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $58K in Q4 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Fusion Family Wealth reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Fusion Family Wealth sold 52 Allergan plc shares in Q2 2020, an estimated $9K.
  • Fusion Family Wealth first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Fusion Family Wealth's Allergan plc position peaked at $58K in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Fusion Family Wealth's 13F filing for Q2 2020, filed 13 Aug 2020.